Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes ...
Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shares in Novavax almost doubled after Sanofi struck a licensing deal worth up to $1.2bn to commercialise ...
Gaithersburg's Novavax is getting a big cash infusion after signing a multibillion-dollar deal with French pharmaceutical ...
Novavax shares jumped 50% on Monday following its recent licensing deal with Sanofi, as meme stocks are making a 2021-style ...
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's ...
Novavax (NVAX) shares are skyrocketing after the company announced a $1.2 billion deal with French drugmaker Sanofi (SNY). B.
The biotech company said it would develop a combination Covid and flu shot with Sanofi as part of a billion-dollar deal.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
French drugmaker gains access to Covid shot and other tech Sanofi also takes a small stake in Maryland-based company -rte-company ...